Merck KGaA Company Profile (FRA:MRK)

About Merck KGaA (FRA:MRK)

Industry, Sector and Symbol:

Sector: Healthcare
Industry: N/A
Sub-Industry: N/A
Symbol: FRA:MRK
CUSIP: N/A
Web: N/A

Average Prices:

50 Day Moving Avg: €93.46
200 Day Moving Avg: €102.32

P/E:

Trailing P/E Ratio: 25.189
P/E Growth: 3.740

Dividend:

Dividend Yield: 1.0%

Frequently Asked Questions for Merck KGaA (FRA:MRK)

What is Merck KGaA's stock symbol?

Merck KGaA trades on the FRA under the ticker symbol "MRK."

Where is Merck KGaA's stock going? Where will Merck KGaA's stock price be in 2017?

22 equities research analysts have issued twelve-month target prices for Merck KGaA's stock. Their forecasts range from €94.00 to €123.00. On average, they anticipate Merck KGaA's share price to reach €108.38 in the next year. View Analyst Ratings for Merck KGaA.

Who are some of Merck KGaA's key competitors?

Some companies that are related to Merck KGaA include Partnership Assurance Group PLC (PA), GlaxoSmithKline plc (GSK), AstraZeneca plc (AZN), Shire PLC (SHP), Hospira (HSP), Smith & Nephew plc (SN), Omnicare (OCR), Valeant Pharmaceuticals Intl (VRX), NMC Health PLC (NMC), ConvaTec Group PLC (CTEC), Health Net (HNT), Patheon NV (PTHN), Catalent (CTLT), Mediclinic International PLC (MDC), BIO-TECHNE Corp (TECH), Puma Biotechnology (PBYI), Patterson Companies (PDCO) and WuXi PharmaTech (Cayman) (WX).

MarketBeat Community Rating for Merck KGaA (FRA MRK)

Community Ranking:		2.0 out of 5 ( )
Outperform Votes:		410 (Vote Outperform)
Underperform Votes:		594 (Vote Underperform)
Total Votes:		1,004

MarketBeat's community ratings are surveys of what our community members think about Merck KGaA and other stocks. Vote "Outperform" if you believe the stock will outperform the S&P 500 over the long term. Vote "Underperform" if you believe the stock will underperform the S&P 500 over the long term. You may vote once every thirty days.

Consensus Ratings for Merck KGaA (FRA:MRK) (How are Consensus Ratings Calculated?)

Ratings Breakdown:	13 Hold Ratings, 9 Buy Ratings
Consensus Rating:	Hold (Score: 2.41)
Consensus Price Target:	€108.38

Analysts' Ratings History for Merck KGaA (FRA:MRK)

Show:

Date	Firm	Action	Rating	Price Target
9/21/2017	Kepler Capital Markets	Set Price Target	Buy	€119.00
9/19/2017	Berenberg Bank	Set Price Target	Buy	€116.00
9/19/2017	Goldman Sachs Group, Inc. (The)	Set Price Target	Neutral	€105.00
9/13/2017	Citigroup Inc.	Set Price Target	Buy	€123.00
9/6/2017	J P Morgan Chase & Co	Reiterated Rating	Neutral
9/6/2017	Commerzbank Ag	Set Price Target	Neutral	€109.00
9/6/2017	Independent Research GmbH	Set Price Target	Neutral	€105.00
9/6/2017	Bank of America Corporation	Set Price Target	Buy	€110.00
9/6/2017	Warburg Research	Set Price Target	Buy	€115.00
9/6/2017	BNP Paribas	Set Price Target	Buy	€116.00
9/5/2017	Societe Generale	Set Price Target	Neutral	€103.00
8/31/2017	equinet AG	Set Price Target	Buy	€112.00
8/17/2017	DZ Bank AG	Reiterated Rating	Neutral
8/9/2017	HSBC Holdings plc	Set Price Target	Neutral	€94.00
8/4/2017	Deutsche Bank AG	Set Price Target	Neutral	€106.00
8/3/2017	Nord/LB	Set Price Target	Neutral	€100.00
8/3/2017	S&P Global	Set Price Target	Buy	€110.00
7/26/2017	Credit Suisse Group	Set Price Target	Neutral	€106.00
6/26/2017	Morgan Stanley	Set Price Target	Neutral	€103.00
3/24/2017	Sanford C. Bernstein	Set Price Target	Neutral	€109.00
11/15/2016	Bankhaus Lampe	Set Price Target	Buy	€112.00
11/15/2016	S&P Global Inc.	Set Price Target	Neutral	€103.00
8/5/2016	Baader Bank	Set Price Target	Neutral	€97.00
5/10/2016	Barclays PLC	Set Price Target	Neutral	€87.00
12/11/2015	S&P Equity Research	Set Price Target	Neutral	€104.00

(Data available from 9/22/2015 forward)

Earnings History for Merck KGaA (FRA:MRK)
No earnings announcements for this company have been tracked by MarketBeat.com

Earnings Estimates for Merck KGaA (FRA:MRK)

No earnings estimates for this company have been tracked by MarketBeat.com

Dividend History for Merck KGaA (FRA:MRK)
No dividend announcements for this company have been tracked by MarketBeat.com

Insider Trading History for Merck KGaA (FRA:MRK)
No insider trades for this company have been tracked by MarketBeat.com

Headline Trends for Merck KGaA (FRA:MRK) Latest Headlines for Merck KGaA (FRA:MRK)

Source:

Date	Headline
	Merck KGaA (MRK) Given a €119.00 Price Target at Kepler Capital Markets www.americanbankingnews.com - September 21 at 10:02 AM
	Merck KGaA (MRK) PT Set at €116.00 by Berenberg Bank www.americanbankingnews.com - September 19 at 6:30 AM
	Berenberg Bank Reiterates €116.00 Price Target for Merck KGaA (MRK) www.americanbankingnews.com - September 17 at 7:02 PM
	Merck KGaA (MRK) Receives Consensus Recommendation of "Hold" from Analysts www.americanbankingnews.com - September 16 at 8:16 AM
	Merck KGaA (MRK) Given a €123.00 Price Target at Citigroup Inc. www.americanbankingnews.com - September 13 at 8:36 AM
	Merck KGaA (MRK) Given a €105.00 Price Target at Goldman Sachs Group, Inc. (The) www.americanbankingnews.com - September 11 at 12:36 AM
	Merck KGaA (MRK) Given a €115.00 Price Target by Warburg Research Analysts www.americanbankingnews.com - September 10 at 9:32 PM
	Merck KGaA (MRK) PT Set at €110.00 by Bank of America Corporation www.americanbankingnews.com - September 10 at 9:32 PM
	Merck KGaA (MRK) Given a €116.00 Price Target by BNP Paribas Analysts www.americanbankingnews.com - September 10 at 9:32 PM
	J P Morgan Chase & Co Reiterates Neutral Rating for Merck KGaA (MRK) www.americanbankingnews.com - September 10 at 8:52 PM
	Germany's Merck hires JP Morgan to advise on consumer health review finance.yahoo.com - September 9 at 6:22 AM
	Independent Research GmbH Analysts Give Merck KGaA (MRK) a €105.00 Price Target www.americanbankingnews.com - September 6 at 6:30 AM
	Commerzbank Ag Analysts Give Merck KGaA (MRK) a €109.00 Price Target www.americanbankingnews.com - September 6 at 6:30 AM
	Term Sheet — Tuesday, September 5 fortune.com - September 5 at 5:04 PM
	Germany's Merck Puts Consumer Drugs Business on the Block finance.yahoo.com - September 5 at 5:04 PM
	Slimming Down Will Flatter Merck KGaA finance.yahoo.com - September 5 at 5:04 PM
	Societe Generale Reiterates €103.00 Price Target for Merck KGaA (MRK) www.americanbankingnews.com - September 5 at 8:26 AM
	Merck KGaA Plans Consumer Healthcare Sale After Strategic Review finance.yahoo.com - September 5 at 5:43 AM
	Merck rises 2% after health business is put up for sale finance.yahoo.com - September 5 at 5:43 AM
	Merck KGaA (MRK) Given a €112.00 Price Target at equinet AG www.americanbankingnews.com - August 31 at 6:20 AM
	Merck KGaA (MRK) PT Set at €105.00 by Independent Research GmbH www.americanbankingnews.com - August 28 at 6:32 AM
	3 Things In Biotech You Should Learn Today: August 27, 2017 seekingalpha.com - August 27 at 7:47 PM
	Merck gets EU approval for multiple sclerosis drug www.marketwatch.com - August 26 at 7:25 AM
	[$$] U.K. Biotech Macrophage Gets Merck Backing finance.yahoo.com - August 24 at 9:32 AM
	How Merck Performed in 2Q17 finance.yahoo.com - August 24 at 9:32 AM
	Merck KGaA (MRK) Given Average Rating of "Hold" by Brokerages www.americanbankingnews.com - August 22 at 8:34 AM
	Merck KGaA (MRK) Given a €105.00 Price Target by Goldman Sachs Group, Inc. (The) Analysts www.americanbankingnews.com - August 20 at 6:22 PM
	Merck KGaA (MRK) PT Set at €109.00 by Berenberg Bank www.americanbankingnews.com - August 20 at 12:50 AM
	Can Pfizer Bank on New Immunotherapy Bavencio for Growth? www.nasdaq.com - August 17 at 3:39 PM
	DZ Bank AG Reaffirms Neutral Rating for Merck KGaA (MRK) www.americanbankingnews.com - August 17 at 11:38 AM
	Merck KGaA (MRK) Given Neutral Rating at J P Morgan Chase & Co www.americanbankingnews.com - August 6 at 7:40 PM
	Merck KGaA (MKGAF) Q2 Earnings Up Y/Y finance.yahoo.com - August 4 at 5:25 AM
	Merck KGaA (FRA:MRK) Given a €100.00 Price Target by Nord/LB Analysts www.americanbankingnews.com - August 3 at 10:29 AM
	Merck KGaA (MRK) Given a €109.00 Price Target by Commerzbank Ag Analysts www.americanbankingnews.com - August 3 at 9:40 AM
	S&P Global Analysts Give Merck KGaA (FRA:MRK) a €110.00 Price Target www.americanbankingnews.com - August 3 at 8:30 AM
	Warburg Research Analysts Give Merck KGaA (MRK) a €116.00 Price Target www.americanbankingnews.com - August 3 at 6:32 AM
	Merck KGaA (MRK) Receives Average Rating of "Hold" from Analysts www.americanbankingnews.com - July 28 at 8:28 AM
	Merck KGaA (FRA:MRK) Given a €110.00 Price Target at Goldman Sachs Group, Inc. (The) www.americanbankingnews.com - July 27 at 11:50 AM
	What's in the Cards for Merck KGaA (MKGAF) in Q2 Earnings? finance.yahoo.com - July 25 at 4:07 AM
	Celgene Endorsement Sees Beigene Come Of Age seekingalpha.com - July 8 at 12:46 PM
	Merck KGaA (FRA:MRK) Receives Consensus Rating of "Hold" from Analysts www.americanbankingnews.com - July 3 at 10:59 AM
	Merck KGaA (MRK) Rating Reiterated by Nord/LB www.americanbankingnews.com - July 2 at 1:56 PM
	Morgan Stanley Analysts Give Merck KGaA (MRK) a €103.00 Price Target www.americanbankingnews.com - June 26 at 11:34 AM
	Merck KGaA (MRK) Given a €115.00 Price Target at Independent Research GmbH www.americanbankingnews.com - June 26 at 11:34 AM
	Germany's Merck gets EU backing for oral MS drug finance.yahoo.com - June 23 at 8:08 AM
	Merck KGaA (MRK) Given a €103.00 Price Target at Morgan Stanley www.americanbankingnews.com - June 18 at 4:58 PM
	A tale of two Mercks: German life-sciences giant opens Austin innovation office www.bizjournals.com - June 13 at 6:46 AM
	Merck KGaA: 2 bln eur pipeline potential driven by cancer, MS drugs finance.yahoo.com - June 12 at 4:00 PM
	Merck KGaA (MRK) Given a €103.00 Price Target by Morgan Stanley Analysts www.americanbankingnews.com - June 11 at 2:02 PM
	Merck KGaA's (MRK) "Neutral" Rating Reaffirmed at JPMorgan Chase & Co. www.americanbankingnews.com - June 7 at 10:26 AM